3. Finding the target
Crystallography
Pre-clinical trials,
Clinical trials
Protein
structure
Drug Development Diagram
Synthesis and testing
Available compound or
lead compounds, substrates
Protein
structure
Lead
Improvement
12. Characterization of truncated form of MMP-9
- TIMP-1 binds and inhibits the catalytic domain
- Fibronectin-like domain is not sufficient for
heparin binding
Zn2+
C
F
~38kD
Sadatmansoori, S (2001) protein expression and purification 23(3) 447-452.
20. The problem: Termite
- $1 billion damage a year!
- 1000 lbs wood a year!
- $15 million effort a year
- Inhibition of digestive enzymes
- The best choice is Cellulase.
38. Acknowledgement
-Dr. Edgar Meyer - Dr. Linda A. Guarino
- Dr. Hirofumi Watanabe - Dr. Arnold Wartenberg
- Dr. Sepideh Sadatmansoori - Dr. Reza Forough
- Dr. Erik Meyer
- Dr. Stanley and Rosemarie Swanson
- Robert A. Welch Foundation
- Texas Advanced Technology Program